Cargando…
A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols
BACKGROUND: The introduction of antibody markers to identify undesired cell populations in flow-cytometry based assays, so called DUMP channel markers, has become a practice in an increasing number of labs performing HLA-peptide multimer assays. However, the impact of the introduction of a DUMP chan...
Autores principales: | Attig, Sebastian, Price, Leah, Janetzki, Sylvia, Kalos, Michael, Pride, Michael, McNeil, Lisa, Clay, Tim, Yuan, Jianda, Odunsi, Kunle, Hoos, Axel, Romero, Pedro, Britten, Cedrik M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148571/ https://www.ncbi.nlm.nih.gov/pubmed/21745365 http://dx.doi.org/10.1186/1479-5876-9-108 |
Ejemplares similares
-
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
por: Britten, Cedrik Michael, et al.
Publicado: (2009) -
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
por: Janetzki, Sylvia, et al.
Publicado: (2007) -
Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring
por: Hoos, Axel, et al.
Publicado: (2012) -
Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer staining
por: Chudley, Lindsey, et al.
Publicado: (2014) -
Immunological Monitoring to Rationally Guide AAV Gene Therapy
por: Britten, Cedrik Michael, et al.
Publicado: (2013)